Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

British journal of cancer·2008

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies.

The oncologist·2001

Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.

Seminars in oncology·1997

Methionine enkephalin: a new cytokine--human studies.

Clinical immunology and immunopathology·1997

Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.

Blood·1994

Defects in ribosomes and translational control in lymphoid leukemia and lymphoma.

Seminars in hematology·2026

Making space for cures: Conditioning for autologous hematopoietic stem cell gene therapies.

Seminars in hematology·2026

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

Seminars in hematology·2026

The current state of cerebral complications of sickle cell disease.

Seminars in hematology·2026

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

Seminars in hematology·2026

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Seminars in hematology·2026

Bone marrow necrosis and rapidly progressive liver metastases after breast-conserving surgery in a 33-year-old woman with triple-negative breast cancer, followed by death 288 days after surgery: a case report.

AME case reports·2026

Extracellular vesicles in the immune regulation of hematological malignancies: mechanisms, prognostic significance, and therapeutic opportunities.

Frontiers in cell and developmental biology·2026

A hepatic malignant spindle-cell neoplasm of uncertain lineage clinically favoring sarcomatoid hepatocellular carcinoma: a case report.

AME case reports·2026

Unusual paraneoplastic thrombocytosis in small bowel neuroendocrine tumor responding to 177Lu-DOTATATE.

JCEM case reports·2026

Late-onset bilateral pulmonary vein stenosis after living-donor lobar lung transplantation managed with balloon angioplasty: a case report.

AME case reports·2026

Postoperative chylothorax associated with lymphatic channels around the azygos arch after right upper lobectomy: a case report.

AME case reports·2026

Related Experiment Videos

Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents

Related Concept Videos

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study.

Clinical trials of arsenic trioxide in hematologic and solid tumors: overview of the National Cancer Institute Cooperative Research and Development Studies.

Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.

Methionine enkephalin: a new cytokine--human studies.

Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.

Defects in ribosomes and translational control in lymphoid leukemia and lymphoma.

Making space for cures: Conditioning for autologous hematopoietic stem cell gene therapies.

Closing the disease modification gap: Emerging therapies in myelofibrosis beyond JAK inhibition.

The current state of cerebral complications of sickle cell disease.

Blood or marrow transplantation and cellular therapies in myeloproliferative neoplasms: A comprehensive review.

The thrombopoietin receptor in myeloproliferative neoplasms: A unifying mechanism of disease pathogenesis and therapeutic targeting.

Bone marrow necrosis and rapidly progressive liver metastases after breast-conserving surgery in a 33-year-old woman with triple-negative breast cancer, followed by death 288 days after surgery: a case report.

Extracellular vesicles in the immune regulation of hematological malignancies: mechanisms, prognostic significance, and therapeutic opportunities.

A hepatic malignant spindle-cell neoplasm of uncertain lineage clinically favoring sarcomatoid hepatocellular carcinoma: a case report.

Unusual paraneoplastic thrombocytosis in small bowel neuroendocrine tumor responding to 177Lu-DOTATATE.

Late-onset bilateral pulmonary vein stenosis after living-donor lobar lung transplantation managed with balloon angioplasty: a case report.

Postoperative chylothorax associated with lymphatic channels around the azygos arch after right upper lobectomy: a case report.

Related Experiment Videos

Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents

Related Concept Videos

Related Articles